Voyageur Pharmaceuticals (CVE:VM) Stock Price Up 21.2% – Still a Buy?

Voyageur Pharmaceuticals Ltd. (CVE:VM)’s share price rose 21.2% during mid-day trading on Thursday . The company traded as high as C$0.21 and last traded at C$0.20. Approximately 292,294 shares were traded during mid-day trading, a decline of 46% from the average daily volume of 538,273 shares. The stock had previously closed at C$0.17.

Voyageur Pharmaceuticals Stock Up 21.2 %

The stock has a 50 day moving average of C$0.10 and a 200-day moving average of C$0.07. The firm has a market capitalization of C$27.89 million, a P/E ratio of -20.00 and a beta of 0.32. The company has a debt-to-equity ratio of 3.21, a quick ratio of 0.84 and a current ratio of 0.17.

Voyageur Pharmaceuticals Company Profile

Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in the acquiring, exploring, and developing raw materials for pharmaceutical products, primarily in the province of British Columbia, Canada, and the state of Utah. The company develops barium and iodine-based APIs. The company was formerly known as Voyageur Minerals Ltd.